George Kouvatseas Selected Research

George Kouvatseas Research Topics

Disease

18	Neoplasms (Cancer) 01/2018 - 11/2012
13	Breast Neoplasms (Breast Cancer) 01/2018 - 10/2007
5	Colorectal Neoplasms (Colorectal Cancer) 12/2015 - 02/2013
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2017 - 05/2013
2	Colonic Neoplasms (Colon Cancer) 05/2014 - 02/2014
2	Neoplasm Metastasis (Metastasis) 02/2013 - 02/2013
1	Urinary Bladder Neoplasms (Bladder Cancer) 11/2021
1	Disease Progression 01/2018
1	Brain Neoplasms (Brain Tumor) 09/2017
1	Infections 09/2017
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 10/2013
1	Drug-Related Side Effects and Adverse Reactions 01/2013
1	Renal Cell Carcinoma (Grawitz Tumor) 09/2010

Drug/Important Bio-Agent (IBA)

11	ParaffinIBA 01/2018 - 11/2012
8	Formaldehyde (Formol)FDA Link 01/2018 - 11/2012
7	Messenger RNA (mRNA)IBA 01/2018 - 11/2012
6	Biomarkers (Surrogate Marker)IBA 11/2021 - 02/2013
5	Proteins (Proteins, Gene)FDA Link 01/2018 - 10/2013
3	DNA (Deoxyribonucleic Acid)IBA 11/2021 - 01/2013
3	AnthracyclinesIBA 01/2018 - 01/2016
3	ErbB Receptors (EGF Receptor)IBA 01/2018 - 01/2014
3	Phenobarbital (Luminal)FDA Link 01/2017 - 02/2013
3	Hormones (Hormone)IBA 01/2016 - 01/2014
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2014 - 11/2012
3	Cetuximab (Erbitux)FDA Link 05/2014 - 02/2013
2	thiamine triphosphorate (TTP)IBA 01/2018 - 05/2014
2	Tyrosine Kinase InhibitorsIBA 09/2017 - 09/2010
2	Cyclin D1IBA 01/2017 - 10/2013
2	ixabepilone (BMS 247550)FDA Link 10/2014 - 01/2013
2	Paclitaxel (Taxol)FDA LinkGeneric 10/2014 - 11/2012
2	Bevacizumab (Avastin)FDA Link 10/2014 - 02/2014
2	Monoclonal AntibodiesIBA 12/2013 - 02/2013
2	human ERBB2 proteinIBA 12/2013 - 11/2012
2	RNA (Ribonucleic Acid)IBA 02/2013 - 11/2012
1	Trastuzumab (Herceptin)FDA Link 01/2018
1	Lapatinib (GW572016)FDA Link 09/2017
1	Dexamethasone (Maxidex)FDA LinkGeneric 09/2017
1	Phosphotransferases (Kinase)IBA 09/2017
1	Tyrosine (L-Tyrosine)FDA Link 09/2017
1	OsteopontinIBA 01/2017
1	CyclinsIBA 01/2017
1	Taxoids (Taxanes)IBA 01/2016
1	Amino Acids FDA Link 01/2016
1	Docetaxel (Taxotere)FDA Link 10/2014
1	Protein Isoforms (Isoforms)IBA 10/2014
1	PTEN Phosphohydrolase (PTEN Phosphatase)IBA 05/2014
1	Neutralizing AntibodiesIBA 02/2014
1	Tumor Biomarkers (Tumor Markers)IBA 02/2014
1	Somatomedin Receptors (Somatomedin Receptor)IBA 01/2014
1	EpiregulinIBA 12/2013
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2013
1	AmphiregulinIBA 12/2013
1	Ephrin-A2 (Ephrin A2)IBA 12/2013
1	Carrier Proteins (Binding Protein)IBA 12/2013
1	Insulin (Novolin)FDA Link 12/2013
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 12/2013
1	Growth Factor ReceptorsIBA 12/2013
1	WD repeat containing planar cell polarity effectorIBA 10/2013
1	Cadherins (E-Cadherin)IBA 10/2013
1	Matrix Metalloproteinase 7 (Matrilysin)IBA 10/2013
1	CateninsIBA 10/2013
1	Vinorelbine (Navelbine)FDA LinkGeneric 05/2013
1	Codon (Codons)IBA 02/2013
1	LigandsIBA 02/2013
1	Estrogen ReceptorsIBA 11/2012
1	Vascular Endothelial Growth Factor CIBA 11/2012
1	Epirubicin (Ellence)FDA LinkGeneric 11/2012
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2012
1	Fluorouracil (Carac)FDA LinkGeneric 11/2012
1	Progesterone Receptors (Progesterone Receptor)IBA 11/2012
1	Methotrexate (Mexate)FDA LinkGeneric 11/2012
1	Sunitinib (Sutent)FDA Link 09/2010
1	Brain Natriuretic Peptide (Natrecor)FDA Link 09/2010
1	AntibodiesIBA 10/2007

Therapy/Procedure

7	Drug Therapy (Chemotherapy) 01/2018 - 11/2012
6	Adjuvant Chemotherapy 01/2018 - 01/2013
3	Therapeutics 12/2013 - 10/2007
1	Radiotherapy 09/2017
1	Semiconductors 01/2016
1	Drug Tapering 12/2015
1	Ligation 02/2014
1	Metastasectomy 02/2014